On August 26, 2020 Can-Fite BioPharma Ltd. (NYSE American:CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, reported that it will be presenting at the 12th annual LD 500 on Tuesday, September 1, 2020 at 9:20 AM EST / 6:20 AM PST (Press release, Can-Fite BioPharma, AUG 26, 2020, View Source [SID1234564056]). The LD 500 will take place on September 1st through the 4th. Investors interested in viewing the presentation may register here: https://ld-micro-conference.events.issuerdirect.com/
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Can-Fite CEO Dr. Pnina Fishman will present to a live public audience, and management will conduct private 1×1 meetings with registered investors. LD Micro expects 20,000 attendees and 300 featured companies. Can-Fite plans to update investors on its advanced clinical pipeline including two ongoing Phase III trials in rheumatoid arthritis and psoriasis, an upcoming pivotal Phase III study in liver cancer, and two upcoming clinical trials in the treatment of COVID-19 and NAFLD/NASH.
Chris Lahiji, Founder of LD stated, "We have been waiting for this moment all year long. Due to COVID, it has been nearly impossible for physical conferences to even take place. I want to show the world that you can still learn, have a great time, and see some of the most unique companies in the capital markets today. All without having to step foot outside. For the first time, LD Micro is accessible to everyone, and we are honored to welcome you to one of the most trusted platforms in the space."
Can-Fite’s profile for the conference may be viewed here: View Source
Profiles powered by LD Micro – News Compliments of ACCESSWIRE
About LD Micro
Back in 2006, LD Micro began with the sole purpose of being an independent resource to the microcap world. What started as a newsletter highlighting unique companies, has transformed into the pre-eminent event platform in the space. The upcoming "500" in September is the Company’s most ambitious project yet, and the first event that is accessible to everyone. For those interested in attending, please contact David Scher at [email protected] or visit www.ldmicro.com for more information.